🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Bone Marrow Transplant (BMT)

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338Phase 1, Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea, Rituximab, Alemtuzumab Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders NCT03128996Phase 1, Phase 24 sites📍 New Haven📍 Wilmington📍 Grand Rapids Washington University School of Medicine · Tests: RIC regimen, GVHD prophylaxis regimen Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation NCT06590285NA1 site📍 San Diego Scripps Health · Tests: App-based Educational Intervention Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia NCT06517641Phase 225 sites📍 Birmingham📍 Duarte📍 Los Angeles Medical College of Wisconsin · Tests: Haploidentical donor bone marrow transplant, Unrelated donor bone marrow transplant Reduced Intensity Haploidentical BMT for High Risk Solid Tumors NCT01804634Phase 23 sites📍 Baltimore📍 The Bronx📍 Valhalla Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Cyclophosphamide, Fludarabine, low dose total body irradiation, Melphalan, Tacrolimus Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies NCT06398457EARLY Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Darzalex Faspro (Daratumumab and hyaluronidase-fihj), JH-DSA Semi-Quant Screen and Response Score BMT-CARE: Psychosocial Intervention for Transplant Caregivers NCT06472089NA3 sites📍 Birmingham📍 Tampa📍 Boston Massachusetts General Hospital · Tests: BMT-CARE, Usual Care HPC Offered for PRESERVE Expansion NCT07145411n/a4 sites📍 Birmingham📍 Detroit📍 Columbus Ossium Health, Inc. · Tests: Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors) The HOPE Biobank Resource (BMT CTN 2402 HOPE) NCT07227155n/a14 sites📍 Duarte📍 Gainesville📍 Atlanta Medical College of Wisconsin Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma NCT03465592Phase 1, Phase 24 sites📍 St. Petersburg📍 Baltimore📍 The Bronx Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Nivolumab Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis NCT03630211Phase 23 sites📍 Pittsburgh📍 Pittsburgh📍 Pittsburgh Paul Szabolcs · Tests: Cyclophosphamide, Mesna, Rituximab, Alemtuzumab, Thiotepa Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure NCT03500731Phase 1, Phase 22 sites📍 Pittsburgh📍 Pittsburgh Paul Szabolcs · Tests: CD3/CD19 negative hematopoietic stem cells, Rituximab, Alemtuzumab, Fludarabine, Thiotepa Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT) NCT06803745NA1 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: 200 cGy or 400 cGy total body irradiation (TBI)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy